Literature DB >> 32618159

Rehabilitation of a severe mandibular atrophy with four millimeter extra-short implant and guided bone regeneration (GBR): case report with 7-years follow-up.

P Carosi1, L Arcuri1, A Pinto1, C Agrestini1, M Laureti2, N Ferrigno2.   

Abstract

The aim of this study was to report the use of extra-short and short implants in combination with Guided Bone Regeneration (GBR) to rehabilitate a case of severe mandibular reabsorption. A 55-yearold female patient asked for a fixed implant supported rehabilitation in 4.5 - 4.6 zone which showed severe atrophy. It was decided to use an extra-short 4 mm length and 4.1 mm Ø, Roxolid and SLActive implant (Straumann Standard Plus Regular Neck, Institut Straumann AG) in 4.5 position and a short 6 mm length and 4.8 mm Ø, Roxolid and SLActive implant (Straumann Standard Plus Wide Neck, Institut Straumann AG) in 4.6 position. The implants supported cemented fixed prosthesis. Examinations were performed at the day of the surgery and up to 7-years in function to evaluate implant stability and periapical radiography. One extra-short implant and one short implant were placed. After 7 years in function no biological or prosthetic complication were recorded. Within the limitation of this case report, the use of short and extra-short implants to support fixed prosthesis seem to be a feasible treatment alternative in severe mandibular atrophy. Copyright 2019 Biolife Sas. www.biolifesas.org.

Entities:  

Keywords:  extrashort implants; mandibular atrophy; short dental implants; short implants

Mesh:

Substances:

Year:  2020        PMID: 32618159

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  1 in total

1.  Prevalence and treatment of retrograde peri-implantitis: a retrospective cohort study covering a 20-year period.

Authors:  Bianca Di Murro; Luigi Canullo; Giorgio Pompa; Carlo Di Murro; Piero Papi
Journal:  Clin Oral Investig       Date:  2021-01-14       Impact factor: 3.573

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.